Application 011287
- Type
- NDA
- Sponsor
- CONCORDIA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | KAYEXALATE | SODIUM POLYSTYRENE SULFONATE | POWDER;ORAL, RECTAL | 453.6GM/BOT **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N011287-001 | KAYEXALATE | SODIUM POLYSTYRENE SULFONATE | 453.6GM/BOT **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / ORAL, RECTAL | RLD, Approved before 1982 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | N011287-001 | KAYEXALATE | 453.6GM/BOT **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / ORAL, RECTAL | RLD, Approved before 1982 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | N011287-001 | KAYEXALATE | 453.6GM/BOT **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / ORAL, RECTAL | RLD, Approved before 1982 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N011287-001 | KAYEXALATE | 453.6GM/BOT **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / ORAL, RECTAL | RLD, Approved before 1982 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N011287-001 | KAYEXALATE | 453.6GM/BOT **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / ORAL, RECTAL | RLD, Approved before 1982 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SODIUM POLYSTYRENE SULFONATE | SODIUM POLYSTYRENE SULFONATE | Bryant Ranch Prepack | d6016e9d-dec6-4f14-b10b-7ec1aba3964a | 2025-10-21 | Warnings, Adverse reactions | SODIUM POLYSTYRENE SULFONATE |
| Kionex | SODIUM POLYSTYRENE SULFONATE | ANI Pharmaceuticals, Inc. | 676c3d81-d575-43f6-8748-e04b7c0cafeb | 2025-09-19 | Warnings, Adverse reactions | SODIUM POLYSTYRENE SULFONATE |
| Sodium Polystyrene Sulfonate | SODIUM POLYSTYRENE SULFONATE | ATLANTIC BIOLOGICALS CORP. | 2d95d23e-94c8-4975-99f5-ce746dfbb60e | 2025-05-27 | Warnings, Adverse reactions | SODIUM POLYSTYRENE SULFONATE |
| SODIUM POLYSTYRENE SULFONATE | SODIUM POLYSTYRENE SULFONATE | Bryant Ranch Prepack | 9a50c6d4-e619-438d-8af9-bb758ea7ba7e | 2025-05-12 | Warnings, Adverse reactions | SODIUM POLYSTYRENE SULFONATE |
| Sodium Polystyrene Sulfonate | SODIUM POLYSTYRENE SULFONATE | Burel Pharmaceuticals, LLC | 8bbeae67-a7ff-4fa6-b21e-fb8617cd9197 | 2025-05-01 | Warnings, Adverse reactions | SODIUM POLYSTYRENE SULFONATE |
| SODIUM POLYSTYRENE SULFONATE | SODIUM POLYSTYRENE SULFONATE | Bryant Ranch Prepack | 03a0b525-5e48-4e76-b1fa-700eab10d20a | 2024-04-12 | Warnings, Adverse reactions | SODIUM POLYSTYRENE SULFONATE |
| SODIUM POLYSTYRENE SULFONATE | SODIUM POLYSTYRENE SULFONATE | Bryant Ranch Prepack | fe1eaaea-0697-4790-8f14-b9db08d42257 | 2024-03-15 | Warnings, Adverse reactions | SODIUM POLYSTYRENE SULFONATE |
| Sodium Polystyrene Sulfonate | SODIUM POLYSTYRENE SULFONATE | KVK-Tech, Inc. | 905c3ee5-d1a7-4deb-a345-4a42296704fa | 2024-02-23 | Warnings, Adverse reactions | SODIUM POLYSTYRENE SULFONATE |
| Sodium Polystyrene Sulfonate | SODIUM POLYSTYRENE SULFONATE | Epic Pharma, LLC | 61cc890b-eb3d-494c-ae45-629a27e721ce | 2023-11-29 | Warnings, Adverse reactions | SODIUM POLYSTYRENE SULFONATE |
| Sodium Polystyrene Sulfonate | SODIUM POLYSTYRENE SULFONATE | Chartwell RX, LLC | e910a2f9-07ee-4e8f-95bd-f124e1306ff7 | 2023-10-05 | Warnings, Adverse reactions | SODIUM POLYSTYRENE SULFONATE |
| SODIUM POLYSTYRENE SULFONATE | SODIUM POLYSTYRENE SULFONATE | Bryant Ranch Prepack | cae5e7d2-c6ca-485e-963e-1a147e5b11c3 | 2023-03-15 | Warnings, Adverse reactions | SODIUM POLYSTYRENE SULFONATE |
| Sodium Polystyrene Sulfonate | SODIUM POLYSTYRENE SULFONATE | PuraCap Laboratories, LLC | 875d5288-db99-4440-8290-d9192bde6eee | 2022-12-28 | Warnings, Adverse reactions | SODIUM POLYSTYRENE SULFONATE |
| SODIUM POLYSTYRENE SULFONATE | SODIUM POLYSTYRENE SULFONATE | SUNRISE PHARMACEUTICAL, INC. | c73b9661-2378-4336-8be0-098e7c1ae522 | 2022-08-12 | Warnings, Adverse reactions | SODIUM POLYSTYRENE SULFONATE |
| Sodium Polystyrene Sulfonate | SODIUM POLYSTYRENE SULFONATE | CMP Pharma, Inc. | 12d48dcf-07bd-4b06-bd6c-7543f1be8357 | 2021-08-15 | Warnings, Adverse reactions | SODIUM POLYSTYRENE SULFONATE |
| Sodium Polystyrene Sulfonate | SODIUM POLYSTYRENE SULFONATE | CMP Pharma, Inc. | 2017bfbe-cda8-46f1-b4f1-9c086c3249a9 | 2021-02-01 | Warnings, Adverse reactions | SODIUM POLYSTYRENE SULFONATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.